BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 25186184)

  • 21. Hereditary and acquired angioedema.
    Patel G; Pongracic JA
    Allergy Asthma Proc; 2019 Nov; 40(6):441-445. PubMed ID: 31690390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH).
    Wedner HJ
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S14-S17. PubMed ID: 33109319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
    Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L
    J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor.
    Bova M; Suffritti C; Bafunno V; Loffredo S; Cordisco G; Del Giacco S; De Pasquale TMA; Firinu D; Margaglione M; Montinaro V; Petraroli A; Radice A; Brussino L; Zanichelli A; Zoli A; Cicardi M
    Allergy; 2020 Jun; 75(6):1394-1403. PubMed ID: 31860755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
    Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
    Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.
    Sinnathamby ES; Issa PP; Roberts L; Norwood H; Malone K; Vemulapalli H; Ahmadzadeh S; Cornett EM; Shekoohi S; Kaye AD
    Adv Ther; 2023 Mar; 40(3):814-827. PubMed ID: 36609679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hereditary angioedema biological diagnosis].
    Ponard D
    Presse Med; 2015 Jan; 44(1):57-64. PubMed ID: 25511654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bradykinin-forming cascade and its role in hereditary angioedema.
    Kaplan AP; Joseph K
    Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chapter 22: Hereditary and acquired angioedema.
    Georgy MS; Pongracic JA
    Allergy Asthma Proc; 2012; 33 Suppl 1():73-76. PubMed ID: 22794695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.
    Magerl M; Germenis AE; Maas C; Maurer M
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis.
    Khan DA
    Allergy Asthma Proc; 2011; 32(1):1-10. PubMed ID: 21262092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
    Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
    Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and laboratory diagnosis of hereditary angioedema.
    Zuraw BL; Christiansen SC
    Allergy Asthma Proc; 2009; 30(5):487-92. PubMed ID: 19843402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.